Chin et al [20] identified a polymorphism in the 3′UTR of KRAS (LCS6) and the LCS6 polymorphism increased lung cancer risk in low-dose smokers (GRADE quality of evidence, low) but this association was not significant in overall population (GRADE quality of evidence, very low). This evidence concerns the gene KRAS and lung cancer.